Reduction in brain atrophy associated with Ethyl-Eicosapentaenoic Acid in Patients with Huntington's disease

2008 ◽  
Vol 23 ◽  
pp. S196 ◽  
Author(s):  
B.K. Puri ◽  
G.M. Bydder ◽  
A. Clarke ◽  
M.S. Manku ◽  
C.F. Beckmann
2008 ◽  
Vol 36 (5) ◽  
pp. 896-905 ◽  
Author(s):  
BK Puri ◽  
GM Bydder ◽  
MS Manku ◽  
A Clarke ◽  
AD Waldman ◽  
...  

Ultra-pure ethyl-eicosapentaenoic acid (ethyl-EPA), a semi-synthetic ethyl ester of eicosapentaenoic acid, is associated with clinical improvement in motor functioning in Huntington's disease. The aim was to determine the extent to which it might reduce the rate of progress of cerebral atrophy. High-resolution cerebral magnetic resonance imaging scans were acquired at baseline, 6 months and 1 year in up to 34 patients with stage I or II Huntington's disease who took part in a randomized, double-blind, placebo-controlled trial of ethyl-EPA. For each subject and each pair of structural images, the two-timepoint brain volume change was calculated in a double-blind manner. Significant group-level reductions in brain atrophy were observed in the head of the caudate nucleus and the posterior thalamus. These findings show that treatment with ethyl-EPA is associated with significant reduction in brain atrophy, particularly in the caudate and thalamus. No other drug tested in Huntington's disease has shown this effect.


1989 ◽  
Vol 31 (2) ◽  
pp. 156-159 ◽  
Author(s):  
S. E. Starkstein ◽  
S. E. Folstein ◽  
J. Brandt ◽  
G. D. Pearlson ◽  
A. McDonnell ◽  
...  

2014 ◽  
Vol 44 (15) ◽  
pp. 3341-3356 ◽  
Author(s):  
R. C. Wolf ◽  
F. Sambataro ◽  
N. Vasic ◽  
M. S. Depping ◽  
P. A. Thomann ◽  
...  

Background.Functional magnetic resonance imaging (fMRI) of multiple neural networks during the brain's ‘resting state’ could facilitate biomarker development in patients with Huntington's disease (HD) and may provide new insights into the relationship between neural dysfunction and clinical symptoms. To date, however, very few studies have examined the functional integrity of multiple resting state networks (RSNs) in manifest HD, and even less is known about whether concomitant brain atrophy affects neural activity in patients.Method.Using MRI, we investigated brain structure and RSN function in patients with early HD (n = 20) and healthy controls (n = 20). For resting-state fMRI data a group-independent component analysis identified spatiotemporally distinct patterns of motor and prefrontal RSNs of interest. We used voxel-based morphometry to assess regional brain atrophy, and ‘biological parametric mapping’ analyses to investigate the impact of atrophy on neural activity.Results.Compared with controls, patients showed connectivity changes within distinct neural systems including lateral prefrontal, supplementary motor, thalamic, cingulate, temporal and parietal regions. In patients, supplementary motor area and cingulate cortex connectivity indices were associated with measures of motor function, whereas lateral prefrontal connectivity was associated with cognition.Conclusions.This study provides evidence for aberrant connectivity of RSNs associated with motor function and cognition in early manifest HD when controlling for brain atrophy. This suggests clinically relevant changes of RSN activity in the presence of HD-associated cortical and subcortical structural abnormalities.


2015 ◽  
Vol 30 (10) ◽  
pp. 1426-1429 ◽  
Author(s):  
Joaquim J. Ferreira ◽  
Anne Rosser ◽  
David Craufurd ◽  
Ferdinando Squitieri ◽  
Nicholas Mallard ◽  
...  

2008 ◽  
Vol 5 (2) ◽  
pp. 366-367 ◽  
Author(s):  
Y MA ◽  
A FEIGIN ◽  
S PENG ◽  
P KINGSLEY ◽  
V DHAWAN ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document